BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34756698)

  • 1. Comparison of dose delivered to vagina using two different intracavitary brachytherapy applicators for carcinoma cervix.
    Bajwa HK; Talluri AK; Maqbool A; Reddy D; Singareddy R; Sresty NM; Raju AK
    Brachytherapy; 2022; 21(2):151-157. PubMed ID: 34756698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients.
    Westerveld H; de Leeuw A; Kirchheiner K; Dankulchai P; Oosterveld B; Oinam A; Hudej R; Swamidas J; Lindegaard J; Tanderup K; Pötter R; Kirisits C;
    Radiother Oncol; 2016 Sep; 120(3):420-427. PubMed ID: 27237058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of intracavitary brachytherapy parameters and correlation with outcome in patients with carcinoma of the cervix.
    Katz A; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1417-25. PubMed ID: 11121642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional applicator system for carcinoma of the uterine cervix.
    Weeks KJ; Montana GS
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):455-63. PubMed ID: 9069321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal dose assessment in image-guided brachytherapy for cervical cancer: Can we really rely on dose-point evaluation?
    Limkin EJ; Dumas I; Rivin Del Campo E; Chargari C; Maroun P; Annède P; Petit C; Seisen T; Doyeux K; Tailleur A; Martinetti F; Lefkopoulos D; Haie-Meder C; Mazeron R
    Brachytherapy; 2016; 15(2):169-76. PubMed ID: 26778755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in Cervical Cancer Brachytherapy: Results From the EMBRACE I Study.
    Serban M; Kirisits C; de Leeuw A; Pötter R; Jürgenliemk-Schulz I; Nesvacil N; Swamidas J; Hudej R; Lowe G; Hellebust TP; Menon G; Oinam A; Bownes P; Oosterveld B; De Brabandere M; Koedooder K; Langeland Marthinsen AB; Whitney D; Lindegaard J; Tanderup K;
    Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):1052-1062. PubMed ID: 32007365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose at posterior-inferior border of symphysis point: A predictor for vaginal stricture in cervical cancer.
    Singh A; Mani N; Aggarwal LM; Agarwal S; Mourya A; Verma A; Bagchi A; Gupta N; Choudhary S
    Brachytherapy; 2023; 22(5):616-622. PubMed ID: 37286402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dosimetric comparison between applicators used for brachytherapy in carcinoma cervix - A single-institute prospective study.
    Suryadevara A; Kumar MV; Vasundhara E; Alluri KR; Ahamed S; Guduru S
    Indian J Cancer; 2018; 55(3):230-232. PubMed ID: 30693884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
    Beriwal S; Kim H; Heron DE; Selvaraj R
    Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To evaluate the use of tandem and cylinder as an intracavitary brachytherapy device for carcinoma of the cervix with regard to local control and toxicities.
    Gadda IR; Khan NA; Wani SQ; Baba MH
    J Cancer Res Ther; 2022; 18(3):740-746. PubMed ID: 35900548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems in reporting doses and volumes during multiple high-dose-rate intracavitary brachytherapy for carcinoma cervix as per ICRU Report 38: a comparative study using flexible and rigid applicators.
    Datta NR; Basu R; Das KJ; Rajasekar D; Pandey CM; Ayyagari S
    Gynecol Oncol; 2003 Nov; 91(2):285-92. PubMed ID: 14599857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
    Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the rectal retractor to reduce the rectal dose in high dose rate intracavitary brachytherapy for a carcinoma of the uterine cervix.
    Lee KC; Kim TH; Choi JH; Choi MS; Kim CY; Kim JY
    Yonsei Med J; 2004 Feb; 45(1):113-22. PubMed ID: 15004877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image-Guided Brachytherapy a Comparison Between 192Ir and 60Co Sources in Carcinoma Uterine Cervix.
    Sinnatamby M; Kandasamy S; Karunanidhi G; Neelakandan V; Ramapandian S; Kannan M; Sampath E
    Gulf J Oncolog; 2022 Jan; 1(38):7-14. PubMed ID: 35156639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study.
    Westerveld H; Kirchheiner K; Nout RA; Tanderup K; Lindegaard JC; Spampinato S; Sturdza A; Nesvacil N; Bruheim K; Hellebust TP; Pieters BR; Kirisits C; Jürgenliemk-Schulz IM; Pötter R; de Leeuw AAC
    Radiother Oncol; 2022 Mar; 168():8-15. PubMed ID: 35063582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of dose distribution from Manchester-style and Fletcher-style intracavitary brachytherapy applicator systems in cervical cancer.
    Basu B; Basu S; Chakraborti B; Ghorai S; Gupta P; Ghosh S; Ghosh K; Jayanti J
    J Contemp Brachytherapy; 2012 Dec; 4(4):213-8. PubMed ID: 23378850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the validity of the superposition principle in dose calculations for intracavitary implants with shielded vaginal colpostats.
    Markman J; Williamson JF; Dempsey JF; Low DA
    Med Phys; 2001 Feb; 28(2):147-55. PubMed ID: 11243337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between tandem and ovoids and interstitial gynecologic template brachytherapy dosimetry using a hypothetical computer model.
    Hsu IC; Speight J; Hai J; Vigneault E; Phillips T; Pouliot J
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):538-43. PubMed ID: 11872302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.